The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...

Bullish option flow detected in CVS Health (CVS) with 33,211 calls trading, 1.7x expected, and implied vol increasing over 7 points to 47.44%.

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...